Contact Us
Grünenthal Ltd
2 Stokenchurch Business Park
Ibstone Road
Stokenchurch
HP14 3FE
www.grunenthal.co.uk
+44 (0)870 3518960
generalenquiriesuk@grunenthal.com
Adverse Events should be reported:
If, as a patient, you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk.
By reporting side effects, you can help provide more information on the safety of this medicine.
Healthcare professionals should also report adverse events. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk. Adverse events should also be reported to Grunenthal Ltd., using the below contact details for our Medical Information department. Quality complaints and medical device adverse incidents should also be reported.
Contact for Medical Information, Reporting Safety and Quality Related Issues:
If you need more information about our products or wish to report an adverse event or product quality related issues, please contact us via the email address or our Medical Information department via the telephone number below:
E-mail: medicalinformationuk@grunenthal.com
Phone: + 44 (0)870 351 8960
Fax: + 44 (0)1494 486 298
This page is provided as a contact service and does not replace the advice of a physician. Grünenthal cannot respond to questions about general medical information or questions regarding your personal medical condition. If you have questions about a specific medical condition, please consult a healthcare professional. Medications cannot be directly ordered through this website.
Grünenthal GmbH
Zieglerstr. 6
52078 Aachen
Germany
Telephone: +49 (0) 241 569 0
Grünenthal Ltd
2 Stokenchurch Business Park
Ibstone Road
Stokenchurch
HP14 3FE
Registered in England: No. 3658396
Corporate executive board
- Gabriel Baertschi (Chief Executive Officer (CEO) Grünenthal Group)
- Fabian Raschke (Chief Financial Officer)
- Mark Fladrich (Chief Commercial Officer)
- Jan Adams, MD (Chief Scientific Officer)
February 2021 M-ALL-UK-09-20-0004